Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and inhibits hepatocellular carcinoma

BACKGROUND & AIMS: Epidemiological studies have shown that obesity is a risk factor for hepatocellular carcinoma (HCC). Lower adiponectin levels are associated with poor prognosis in obese HCC patients hence it is plausible that adiponectin acts as a negative regulator of HCC. Here, we investiga...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Saxena, Neeraj K., Fu, Ping P., Nagalingam, Arumugam, Wang, Jason, Handy, Jeffrey, Cohen, Cynthia, Tighiouart, Mourad, Sharma, Dipali, Anania, Frank A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2967590/
https://ncbi.nlm.nih.gov/pubmed/20637208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2010.07.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados